海爾生物(688139.SH):公司疫苗預約接種系統已接入DeepSeek
格隆匯2月25日丨海爾生物(688139.SH)在互動平台表示,在智慧公衞場景,公司疫苗預約接種系統已接入DeepSeek,基於自然語言處理等技術快速理解用户的多種表達方式,準確解答用户疑問並根據其個性化需求推薦最優接種方案。在院內智慧用藥場景,公司依託DeepSeek-R1大模型的深度學習等能力,構建了AI驅動的動態庫存管理系統、處方前置審核大模型、個體化用藥模型等產品方案,有效降低藥房運營成本、提升智慧藥房的安全性和合規性、推動精準用藥發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.